Pfizer's latest COVID booster targets Omicron JN.1. Learn who should get it and why it’s essential for protection.

The shot was developed by Pfizer and targets the JN.1 sub-variant of Omicron. This is now the fifth iteration of the COVID vaccines, which have been updated regularly to keep up with the rapidly ...

Australia's Therapeutic Goods Administration has approved a new COVID booster by Pfizer targeting the JN.1 sub-variant of Omicron. Despite evolving variants, boosters remain crucial, especially for ...

COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...

Hospital and ICU admission rates within 30 days after COVID-19 infection were greater in patients with inborn errors of immunity (IEI).

The vaccine is part of a recommended vaccine regimen for children ... and attempts to address the rise of FLiRT omicron ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

"At the height of the Omicron wave, we still saw a lot of children being hospitalized," Jennifer Nayak, MD, associate ...

Omicron emerged in December 2021 ... The CDC recommends that people use its core prevention strategies, which includes ...

Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute ...